Details for New Drug Application (NDA): 061396
✉ Email this page to a colleague
The generic ingredient in VERSAPEN-K is hetacillin potassium. There are six drug master file entries for this compound. Additional details are available on the hetacillin potassium profile page.
Summary for 061396
Tradename: | VERSAPEN-K |
Applicant: | Bristol |
Ingredient: | hetacillin potassium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 225MG AMPICIL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 450MG AMPICIL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription